Crucial Role of Membrane Type 1 Matrix Metalloproteinase (MT1- MMP) in RhoA/Rac1-Dependent Signaling Pathways in Thrombin- Stimulated Endothelial Cells

Access this Article

Search this Article

Author(s)

    • Ando Katsuya
    • Department of Cardiology and Hematology, Fukushima Medical University.
    • Ishibashi Toshiyuki
    • Department of Cardiology and Hematology, Fukushima Medical University.|Department of Cardiovascular Medicine, Ohara General Hospital Medical Center.
    • Sugimoto Koichi
    • Department of Cardiology and Hematology, Fukushima Medical University.
    • Uekita Hironori
    • Department of Cardiology and Hematology, Fukushima Medical University.
    • Hu Chengjun
    • Department of Anatomy & Embryology, Wuhan University School of Medicine.
    • Okamoto Yasuo
    • Department of Physiology, Kanazawa University Graduate School of Medicine.
    • Takuwa Yoh
    • Department of Physiology, Kanazawa University Graduate School of Medicine.

Abstract

Aim: Thrombin induces vascular responses including the promotion of tissue factor (TF) and plas-minogen activator inhibitor-1 (PAI-1) protein expression, which is modulated by small GTPases RhoA and Rac1, Ca<sup>2+</sup> signaling and reactive oxygen species (ROS). Recent studies have shown that membrane type 1 matrix metalloproteinase (MT1-MMP) functions not only as a protease but also as a signaling molecule. In this study, we hypothesized that MT1-MMP may mediate RhoA and Rac1 activation and their downstream events in thrombin-stimulated endothelial cells.<BR>Methods: We used cultured human aortic endothelial cells (HAECs). MT1-MMP was silenced by small interfering RNA (siRNA). RhoA was inhibited by C3 exoenzyme, whereas adenovirus-mediated gene transfection of dominant negative RhoA and Rac1 was used for the inhibition of RhoA and Rac1. RhoA and Rac1 activation was determined by pull-down assays. Intracellular Ca<sup>2+</sup> concentrations ([Ca<sup>2+</sup>]<sub>i</sub>) were fluorescently measured by fura-2 assay. NADPH oxidase activity was determined by lucigenin-enhanced chemiluminescence.<BR>Results: Inhibition of RhoA attenuated thrombin-triggered [Ca<sup>2+</sup>]<sub>i</sub> increase and TF and PAI-1 expression in HAECs, whereas thrombin-triggered ROS generation and TF and PAI-1 expression were blocked by inhibition of Rac1. Silencing of MT1-MMP attenuated thrombin-triggered RhoA and Rac1 activation, resulting in the attenuation of downstream events including Ca<sup>2+</sup> signaling, NADPH oxidase activity, ROS generation, and TF and PAI-1 expression.<BR>Conclusions: The present study shows that MT1-MMP mediates the RhoA/Ca<sup>2+</sup> and Rac1/NADPH oxidase-dependent signaling pathways in thrombin-induced vascular responses.

Journal

  • Journal of Atherosclerosis and Thrombosis

    Journal of Atherosclerosis and Thrombosis 18(9), 762-773, 2011

    Japan Atherosclerosis Society

Codes

  • NII Article ID (NAID)
    130004845389
  • Text Lang
    ENG
  • ISSN
    1340-3478
  • Data Source
    J-STAGE 
Page Top